The pheNIX trial: first-in-human gene therapy trial for PKU due to phenylalanine hydroxylase (PAH) deficiency
Keyword(s):
Keyword(s):
1990 ◽
Vol 82
(24)
◽
pp. 1877-1878
◽
Keyword(s):
2019 ◽
Keyword(s):
1992 ◽
Vol 1
(1)
◽
pp. 113-120
◽
Keyword(s):
Keyword(s):